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ISCHEMIA-REPERFUSION
Lovastatin protects mithochondrial and renal function 
in kidney ischemia-reperfusion in rats1
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ABSTRACT
PURPOSE: To investigate the effect of lovastatin on renal ischemia followed by reperfusion.
METHODS: Thirty one Wistar rats submitted to left renal ischemia for 60 minutes followed by contralateral nephrectomy were divided 
into two groups: A (n =17, control, no treatment), and B (n=14, lovastatin 15 mg/kg/day p.o. ten days before ischemia).  The animals 
were sacrificed at the end of ischemia, after 24 hours and at seven days after reperfusion. Survival, serum urea and creatinine levels and 
renal mitochondrial function were evaluated.
RESULTS: Mortality was 29.4% in group A and 0.7% in group B. Urea and creatinine levels were increased in both groups, but the 
values were significantly lower in group B. Mitochondrial function showed decoupling in 83.4% of group A, as opposed to 38.4/% of 
group B.
CONCLUSIONS: The result shows a protective action of renal function by lovastatin administered before ischemia/reperfusion. Since 
most of the mitochondrial fraction presented membranes with the ability to maintain ATP production in group B, stabilization of the 
mitochondrial membrane should be considered as part of the protective action of lovastatin on renal function in ischemia/reperfusion.
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RESUMO
OBJETIVO: Investigar a ação da lovastatina na isquemia renal seguida de reperfusão.
MÉTODOS: Trinta e um ratos Wistar submetidos à isquemia renal esquerda durante 60 minutos, seguida da nefrectomia contralateral, 
foram distribuídos em dois grupos: A (n=17, controle, sem tratamento) e B (n=14, recebendo 15 mg/Kg/dia de lovastatina via oral), 
durante os dez dias que antecederam a isquemia. Os animais foram mortos ao final da isquemia, e com 24 horas e sete dias após a 
reperfusão. Foram avaliadas a sobrevida, os valores séricos de uréia e creatinina e a função mitocondrial renal.
RESULTADOS: A mortalidade foi 29,4% no grupo A e 0,7% no grupo B. Os níveis de uréia e creatinina elevaram-se nos dois grupos, 
mas foram significativamente menores no grupo B. No grupo A a função mitocondrial renal ficou desacoplada em 83,4% dos ensaios, 
enquanto que no grupo B isto ocorreu em apenas 38,4% dos ensaios.
CONCLUSÕES: Os resultados mostram que a administração de lovastatina antes do episódio de isquemia protege a função renal. No 
grupo B, como a maior parte da fração mitocondrial isolada apresentou função acoplada à produção de ATP, deve-se também considerar 
a estabilização da membrana mitocondrial como parte da ação protetora da lovastatina na função renal durante isquemia e reperfusão.
Descritores: Lovastatina. Mitocôndrias. Traumatismo por Reperfusão. Isquemia. Ratos.
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Introduction
Warm renal ischemia is the cause of severe kidney 
injury, possibly resulting in temporary or irreversible renal failure. 
Ischemia is also an important factor in the determination of renal 
parenchyma atrophy during urinary obstruction and it can also 
be involved with the functional deficit observed after kidney 
transplantation. 
The preservation of renal function in order to use a kidney 
for transplantation starts during the preoperative phase of the donor, 
with fluid infusion, ventilatory assistance and pharmacological 
therapy of a patient with brain death being critical elements for 
the maintenance of hemodynamic stability and the consequent 
appropriate blood perfusion of the organ to be removed.
Brain dead patients who are donor candidates may 
become hemodynamically unstable, often requiring the use of 
vasopressor drugs.  Thus, it is common to obtain organs that 
have suffered a variable period of hypoxia or ischemia with a 
consequent deleterious action on the metabolism of renal cells that 
may affect kidney function after transplantation.
Studies by our group have shown that the kidneys of rats 
submitted to warm ischemia for 60 minutes suffer a fall in their 
capacity for ATP synthesis, as observed by the values obtained in 
the evaluation of state III of mitochondrial respiration, a change 
that lasts over a period of one week. However, it is possible to 
protect mitochondrial function with the use of chlorpromazine 
infused before the ischemic episode1,2. A protective effect has also 
been observed with the use of verapamil3. However, no variation 
in ATP production was observed in the analysis of mitochondrial 
function of rat kidneys obtained during the development of 
compensatory renal hypertrophy (which causes an increased renal 
blood flow) followed by ischemia and reperfusion4.
In the past, some studies have demonstrated that 
lovastatin has a beneficial effect on the renal circulation, 
characterized by increased renal blood flow even in normal 
animals5-7. On the basis of the above considerations, the objective 
of the present study was to evaluate the action of lovastatin in 
renal and mitochondrial function during warm renal ischemia and 
reperfusion in rats.
Methods
Thirty one male Wistar rats weighing 200-250g were 
obtained from the Animal Facilities of the Faculty of Medicine of 
Ribeirao Preto, University of Sao Paulo.
Warm ischemia 
The procedures were carried out under general anesthesia 
induced with a combination of Ketamine® and Xylazine® 
administered intramuscularly. The abdominal skin was shaved 
and disinfected with an iodine solution and a median laparotomy 
about 2 cm in length was performed. Ischemia was induced with 
microsurgical vascular clamping of the left renal artery close to 
its origin in the aorta. The laparotomy incision was sutured and 
the animals were placed for 60 minutes in individual boxes lined 
and kept at room temperature. After this period, the animals were 
again anesthetized, the abdominal cavity was reopened and renal 
blood flow was reestablished by removing the vascular clamp 
from the renal artery. Right nephrectomy was then performed. The 
abdominal cavity was sutured and, after recovery from anesthesia, 
the animals were kept in cages with free access to water and ration.
Experimental groups 
The animals were divided into two groups: group 
A (control, n=17) and group B (experimental, n=14). Each 
rat in group B received lovastatin at the dose of 15 mg/kg/day 
administered p.o. during a period of ten days before the episode of 
ischemia. Within each group, the animals were divided into three 
subgroups (I to III) according to the date of sacrifice:
I - End of the period of ischemia (one hour);
II - 24 hours after reperfusion;
III – 7th day after reperfusion.
The kidneys removed at the above time points were used 
for the study of mitochondrial function.
Blood samples were obtained from all subgroups for the 
determination of serum urea and creatinine at the end of ischemia. 
Samples were collected from subgroup II 24 hours after reperfusion 
and from subgroup III on the 3rd and 7th day after reperfusion.
The survival of control animals (group A) was compared 
to that of the experimental animals (group B).
Preparation of the mitochondrial fraction
The kidneys were immediately transferred to containers 
filled with saline at 0°C to 4°C and fragmented. The fragments 
were transferred to containers filled with homogenization medium 
(100 mM Tris, pH 7.4, 210mM manitol, 70 mM saccharose 
and10 mM EDTA in a volume of approximately 10 ml) and 
triturated three times for three seconds at one minute intervals in 
a Turrax type homogenizer at 100 to 150 rpm. After cell lysis, 
the suspension was processed in a refrigerated centrifuge at 4°C 
(HITACHI – HIMAC CR 21 ) for three cycles, the first at 750g 
for five minutes and the other two at 11.200g for ten minutes. The 
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precipitate resulting from the last centrifugation contained the 
mitochondrial fraction.
Study of mitochondrial function
The basic parameters of mitochondrial respiration, i.e. 
state III, state IV and respiratory control ratio (RCR = state III/
state IV), were determined.
Statistical analysis
Serum urea and creatinine data were analyzed statistically 
by the Kruskal-Wallis method.
Results
Data were available for analysis in 12 animals of group 
A and 13 of group B.
Survival 
Five deaths occurred in the control group (29.4%) during 
the postoperative period of one week, as opposed to only one death 
(0.7%) in group B during the same period.
Renal function 
Serum urea and creatinine values are presented in Tables 
1 and 2. Table 1 shows that at the end of 60 minutes of ischemia 
there was no significant difference in serum urea concentration 
between groups (p>0.05) as also observed for creatinine 
concentration (Table 2). After 24 hours there was an increase in 
serum urea concentration in both groups with significantly higher 
values in the control group (p<0.001) compared to the group 
pretreated with lovastatin. A similar behavior was observed for 
serum creatinine (p<0.01). The serum urea and creatinine levels 
of the control group were still significantly higher on the 3rd 
postoperative day compared to the experimental group (p<0.001). 
On the 7th postoperative day, urea and creatinine concentrations 
tended to decrease in both groups, with no significant difference 
between them (p>0.05).
TABLE 1 - Mean ± SEM serum urea levels (mg%) of 
animals submitted to warm renal ischemia for 1 hour followed by 
contralateral nephrectomy, pretreated or not with lovastatin at the 
dose of 15 mg/kg/day for ten days.
UREA 1 Hour 24 Hours 3 Days 7 Days Mortality
Group A 48.3 ± 12 323 ± 51 374.8 ± 32 189.6 ± 97 5 Rats
n 12 7 5 5
Group B 52 ± 16 165.87 ± 71 179 ± 106 86 ± 29 1 Rat
n 13 8 4 5
TABLE 2 - Mean ± SEM serum creatinine levels (mg%) 
of animals submitted to warm renal ischemia for one hour followed 
by contralateral nephrectomy, pretreated or not with lovastatin at 
the dose of 15 mg/kg/day for ten days.
CREATININE 1 Hour 24 Hours 3 Days 7 Days Mortality
Group A 0.61 ± 0.11 3.45 ± 0.69 4.4 ± 1.61 1.78 ± 0.58 5 Rats
n 12 7 5 5
Group B 0.76 ± 0.17 2.03 ± 0.9 1.6 ± 0.6 0.84 ± 0.25 1 Rat
n 13 8 5 5
Mitochondrial function 
At the different time points studied, evaluation of 
mitochondrial function showed that ten of the 12 control animals 
(83.4%) presented decoupling of respiratory function from  the 
function of ATP synthesis, as opposed to only five of the 13 
animals pretreated with lovastatin (38.4%). 
Discussion
Statins are drugs with a potent anti-inflammatory activity 
and a broad range of beneficial effects on the renal parenchyma 
including protection against ischemia/reperfusion injury and 
obstructive nephropathy and beneficial effects on patients with 
type 2 diabetes8,9. 
Statins are believed to act on renal hemodynamics by 
increasing renal blood flow, with an antioxidant and vascular 
endothelium-regulatory action, regardless of their capacity to 
reduce serum lipid levels. This was demonstrated in experimental 
studies with the combination of ischemia and cyclosporine A that 
has a nephrotoxic and vasoconstricting action side by side with 
its immunosuppressor effect10,11. Another mechanism of action of 
statins concerns the promotion of angiogenesis, as suggested by 
Chade et al.12.
More recently, Gottmann et al.13 reported a possible 
mechanism of action of atorvastatin. Using a renal transplant 
model in rats the authors demonstrated that animals treated 
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with atorvastatin showed inhibition of aldose-reductase and 
concomitant improvement of renal function after prolonged cold 
preservation. 
Analysis of the results obtained in the present study 
supports the protective action of lovastatin on the renal function 
of rats pretreated with the drug and submitted to renal ischemia 
for 60 minutes, followed by reperfusion with a follow-up of seven 
days. The activity of lovastatin was evident when the survival of 
the two groups was compared. Whereas mortality was 0.7% over 
a period of seven days after reperfusion in pretreated animals, it 
reached a 29.4% rate in the control group over the same period of 
time.
Another result that supports this effect on renal 
function is presented in Table 2. After the increase in urea and 
creatinine levels observed after 24 hours in both groups, on the 
3rd postoperative day these values continued to increase in the 
control group, whereas serum levels were reduced in the animals 
pretreated with lovastatin compared to the results obtained after 24 
hours of reperfusion.
An interesting question raised in the literature concerns 
the time of administration and the dose of statins. Using a model 
of ischemia and reperfusion in rats, Nesic et al.14 and Tedorovic et 
al.15 reported the protective effects on renal function of simvastatin 
administered as a single dose before ischemia or before reperfusion. 
In the present study lovastatin was administered by gavage for 
ten days before the induction of ischemia. The positive results 
obtained in the two studies within this wide variation in time and 
dose may be related to the different statins used (simvastatin x 
lovastatin). This suggests the need for new studies involving more 
detailed aspects of both the functional and structural renal action 
of statins. 
An original feature of the present study was the evaluation 
of mitochondrial function. This analysis showed that the isolated 
mitochondrial fraction presented membranes of better quality in 
the group pretreated with lovastatin, with the mitochondria being 
coupled to the production of ATP in most of the animals (61.6%). 
A different result was observed in the control group, in which 
functional decoupling was more frequent (83.4%). Decoupling 
indicates that the integrity of the mitochondrial membrane 
was affected after the period of ischemia and reperfusion, with 
difficulty in maintaining ATP production. 
The action of ischemia and reperfusion was also 
manifested in the mitochondrial fraction obtained from animals 
pretreated with lovastatin, since part of the animals (38.4%) showed 
decoupling. However, most of the mitochondrial fraction (61.6%) 
presented membranes with the ability to maintain ATP production. 
Although it is difficult to compare mitochondrial function between 
the two groups due to the results obtained for untreated animals, 
it is possible to consider that the presence of mitochondria of 
better quality with membranes protected by lovastatin against 
the deleterious action of ischemia and reperfusion contributed to 
the rapid functional recovery of these animals. These findings, 
however, should be confirmed in future studies.     
  
Conclusions
  
The protective mechanism of lovastatin on renal function 
after ischemia and reperfusion observed here may have been due to 
the direct action of the drug on renal vascularization, as previously 
reported in the literature. However, we should also consider the 
additional possibility of a protective effect of lovastatin on the 
stabilization of the mitochondrial membrane.
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